A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans
Pediatric Anesthesia · 2024
DOI: 10.1111/pan.14857 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Umar Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Assistant Professor of Anesthesiology and Pain Management, Department of Anesthesiology and Pain Management, Children's Health System Texas,…. Hauptthemen laut MEDLINE: Dexmedetomidine, Propofol. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Dexmedetomidine is a selective α 2 ‐adrenergic agonist originally approved for sedation of adults in the intensive care unit and subsequently approved for procedural sedation in adults undergoing medical procedures. Dexmedetomidine is widely used off‐label for procedural sedation in children.
Aims
To evaluate efficacy and safety of monotherapy dexmedetomidine for magnetic resonance imaging procedural sedation of children ≥1month–
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Assistant Professor of Anesthesiology and Pain Management, Department of Anesthesiology and Pain Management, Children's Health System Texas, Dallas, Texas, USA.
- Professor, Anesthesiology, Perioperative and Pain Medicine, and Pediatrics, Stanford University, Stanford, California, USA.
- Department of Anesthesiology, Division of Pediatric Anesthesiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Department of Critical Care and Anesthesia, National Center for Child Health and Development, Tokyo, Japan.
- Post Approval Clinical Development, Pfizer, Inc., New York, New York, USA.
ORCID-Profile: Gregory B Hammer, Phillip Chappell
Förderung
- Pfizer
Zitieren
APA
Khan, U., Hammer, G. B., Duncan-Azadi, C., Suzuki, Y., Chiles, D., Chime, S., & Chappell, P. (2024). A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans. Pediatric Anesthesia. https://doi.org/10.1111/pan.14857
Vancouver
Khan U, Hammer GB, Duncan-Azadi C, Suzuki Y, Chiles D, Chime S, et al. A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans. Pediatric Anesthesia. 2024. doi:10.1111/pan.14857
BibTeX
@article{Khan2024,
author = {Khan, Umar and Hammer, Gregory B and Duncan-Azadi, Cassandra and Suzuki, Yasuyuki and Chiles, Deborah and Chime, Sunring and Chappell, Phillip},
title = {A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans},
journal = {Pediatric Anesthesia},
year = {2024},
doi = {10.1111/pan.14857}
}
EUVIMED